Report cover image

Artificial Tears Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published Dec 01, 2024
Length 135 Pages
SKU # FOB19410868

Description

Artificial Tears Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Artificial Tears Market

The artificial tears market size was valued at USD 2.64 billion in 2019, and the market is now projected to grow from USD 2.64 billion in 2019 to USD 4.30 billion by 2027, exhibiting a CAGR of 5.9% during the forecast period of 2019-2027.

Pandemic is expected to have dual influences on markets. Governments have carried out strict lockdowns to limit virus spread, however the healthcare industry has confronted challenges. Non-important clinical tactics and consultations had been postponed or canceled, whilst over the counter (OTC) products have visible a positive impact due to on line pharmacies providing those products without restrictions. As an end result, the 2019-20 pandemic is predicted to have a fantastic effect on the worldwide marketplace.

The global market is driven by the growing occurrence of dry eye syndrome, which isn't always existence-threatening but can appreciably impact sufferers' fine of existence. The incidence stages from 9.5-90%, with big patient populations becoming greater privy to this disorder. Despite now not causing tremendous imaginative and prescient problems, dry eye syndrome can substantially lessen a patient's high-quality of existence. This trend is predicted to further increase the market growth throughout the forecast period, as sufferers are getting greater aware about the condition and its potential effect on their fine of lifestyles.

The international artificial tears market growth is experiencing a surge in customer focus of ocular diseases, along with dry eye syndrome, which could negatively impact patients' great of existence. This focus is fueled by means of agencies concerned in manufacturing and governmental organizations, which includes the National Institutes of Health (NIH) within the U.S., which celebrates the month of July as 'National Dry Eye Awareness Month'. These initiative goal to elevate focus about the disease and put into effect powerful measures to alleviate it. These developments are predicted to noticeably boost marketplace sales in the course of the forecast duration.

Comprehensive Analysis of Artificial Tears Market

The artificial tears market in 2019 is divided into three segments: PEG, PPG, and cellulose. The PEG and PPG segment is dominant, with products like Refresh Optive and GenTeal Tears in this segment. The cellulose segment is projected to be the second-largest, with products like Refresh Optive and GenTeal Tears in this segment. The lipid-based artificial tears segment is expected to have a lower market share and growth rate due to lack of prominent product launches. The delivery segment is divided into eye drops and ointments, with eye drops dominating due to numerous product offerings. The application section is divided into dry eye syndrome, allergies and infections, and others. The distribution channel for synthetic tears is segmented into sanatorium pharmacies, drug stores and retail pharmacies, and on line pharmacies.

The North America region lead the artificial tears market share by benefitting a market size of USD 1.38 billion in 2019 due to strong healthcare expenditure, contemporary product adoption, key marketplace players, and prevalence of dry eye syndrome and eye allergies. The 2013 National Health and Wellness Survey expected that up to 6.8% of the United States population turned into tormented by dry eye syndrome, with about 22.4 million sufferers in 2019. This high occurrence is predicted to power the marketplace inside the area, contributing to its international dominance.

The listing of key market players is as follows: Allergam (AbbVie Inc.), Santen Pharmaceutical Co., Ltd., Bausch and Lomb, Alcon, Novartis AG, Akorn Inc., Eyevance Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Johnson and Johnson, Bayer AG, and Otsuka Pharmaceutical Co., Ltd. Other players also are mentioned.

Bausch Lomb, has launched Biotrue Hydration Boost Lubricant Eye Drops and Biotrue Micellar Eyelids Cleansing Wipes.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2016-2027

Base Year 2019

Forecast Period 2020-2027

Historical Period 2016-2018

Unit Value (USD Billion)

SegmentationType, Delivery, Application, Distribution Channel, and Geography

By Type

Polyethylene Glycols (PEG) and Polypropylene Glycols (PPG)

Cellulose

Others

By Delivery

Eye Drops

Ointments

By Application

Dry Eye Syndrome

Allergies & Infections

Others

By Distribution Channel

Hospital Pharmacies

Drug Stores & Retail Pharmacies

Online Pharmacies

By GeographyNorth America (The U.S.,Canada)

Europe (UK, Germany, France, Italy, Spain, Scandinavia,Rest of Europe)

Asia Pacific (Japan, China, India, Australia, Southeast Asia, Rest of Asia Pacific)

Latin America (Brazil, Mexico,Rest of South America)

Middle East & Africa (South Africa, GCC Countries,Rest of Middle East & Africa)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

135 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Prevalence of Dry Eye Disease - By Key Countries
4.2. Prevalence of Conjunctivitis - By Key Countries
4.3. Pipeline Analysis
4.4. Key Industry Developments
4.5. New Product Launches
4.6. Regulatory Scenario - By Key Countries
4.7. Reimbursement Scenario - By Key Countries
4.8. R&D Advancements in Artificial Tears
5. Global Artificial Tears Market Analysis, Insights and Forecast, 2016-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Type
5.2.1. Polyethylene Glycols (PEG) and Polypropylene Glycols (PPG)
5.2.2. Cellulose
5.2.3. Others
5.3. Market Analysis, Insights and Forecast – By Delivery
5.3.1. Eye Drops
5.3.2. Ointments
5.4. 5.4 Market Analysis, Insights and Forecast – By Application
5.4.1. Dry Eye Syndrome
5.4.2. Allergies & Infections
5.4.3. Others
5.5. Market Analysis, Insights and Forecast – By Distribution Channel
5.5.1. Hospital Pharmacies
5.5.2. Drug Stores & Retail Pharmacies
5.5.3. Online Pharmacies
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
6. North America Artificial Tears Market Analysis, Insights and Forecast, 2016-2027
6.1. Key Findings / Summary
6.2. Market Analysis – By Type
6.2.1. Polyethylene Glycols (PEG) and Polypropylene Glycols (PPG)
6.2.2. Cellulose
6.2.3. Others
6.3. Market Analysis – By Delivery
6.3.1. Eye Drops
6.3.2. Ointments
6.4. Market Analysis – By Application
6.4.1. Dry Eye Syndrome
6.4.2. Allergies & Infections
6.4.3. Others
6.5. Market Analysis – By Distribution Channel
6.5.1. Hospital Pharmacies
6.5.2. Drug Stores & Retail Pharmacies
6.5.3. Online Pharmacies
6.6. Market Analysis – By Country
6.6.1. U.S.
6.6.2. Canada
7. Europe Artificial Tears Market Analysis, Insights and Forecast, 2016-2027
7.1. Key Findings / Summary
7.2. Market Analysis – By Type
7.2.1. Polyethylene Glycols (PEG) and Polypropylene Glycols (PPG)
7.2.2. Cellulose
7.2.3. Others
7.3. Market Analysis – By Delivery
7.3.1. Eye Drops
7.3.2. Ointments
7.4. Market Analysis – By Application
7.4.1. Dry Eye Syndrome
7.4.2. Allergies & Infections
7.4.3. Others
7.5. Market Analysis – By Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2. Drug Stores & Retail Pharmacies
7.5.3. Online Pharmacies
7.6. Market Analysis – By Country/ Sub-region
7.6.1. U.K.
7.6.2. Germany
7.6.3. France
7.6.4. Spain
7.6.5. Italy
7.6.6. Scandinavia
7.6.7. Rest of Europe
8. Asia Pacific Artificial Tears Market Analysis, Insights and Forecast, 2016-2027
8.1. Key Findings / Summary
8.2. Market Analysis – By Type
8.2.1. Polyethylene Glycols (PEG) and Polypropylene Glycols (PPG)
8.2.2. Cellulose
8.2.3. Others
8.3. Market Analysis – By Delivery
8.3.1. Eye Drops
8.3.2. Ointments
8.4. Market Analysis – By Application
8.4.1. Dry Eye Syndrome
8.4.2. Allergies & Infections
8.4.3. Others
8.5. Market Analysis – By Distribution Channel
8.5.1. Hospital Pharmacies
8.5.2. Drug Stores & Retail Pharmacies
8.5.3. Online Pharmacies
8.6. Market Analysis – By Country/ Sub-Region
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. Australia
8.6.5. Southeast Asia
8.6.6. Rest of Asia Pacific
9. Latin America Artificial Tears Market Analysis, Insights and Forecast, 2016-2027
9.1. Key Findings / Summary
9.2. Market Analysis – By Type
9.2.1. Polyethylene Glycols (PEG) and Polypropylene Glycols (PPG)
9.2.2. Cellulose
9.2.3. Others
9.3. Market Analysis – By Delivery
9.3.1. Eye Drops
9.3.2. Ointments
9.4. Market Analysis – By Application
9.4.1. Dry Eye Syndrome
9.4.2. Allergies & Infections
9.4.3. Others
9.5. Market Analysis – By Distribution Channel
9.5.1. Hospital Pharmacies
9.5.2. Drug Stores & Retail Pharmacies
9.5.3. Online Pharmacies
9.6. Market Analysis – By Country/ Sub-Region
9.6.1. Brazil
9.6.2. Mexico
9.6.3. Rest of Latin America
10. Middle East & Africa Artificial Tears Market Analysis, Insights and Forecast, 2016-2027
10.1. Key Findings / Summary
10.2. Market Analysis – By Type
10.2.1. Polyethylene Glycols (PEG) and Polypropylene Glycols (PPG)
10.2.2. Cellulose
10.2.3. Others
10.3. Market Analysis – By Delivery
10.3.1. Eye Drops
10.3.2. Ointments
10.4. Market Analysis – By Application
10.4.1. Dry Eye Syndrome
10.4.2. Allergies & Infections
10.4.3. Others
10.5. Market Analysis – By Distribution Channel
10.5.1. Hospital Pharmacies
10.5.2. Drug Stores & Retail Pharmacies
10.5.3. Online Pharmacies
10.6. Market Analysis – By Country/ Sub-Region
10.6.1. GCC Countries
10.6.2. South Africa
10.6.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2019)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
11.5.1. Allergan (AbbVie Inc.)
11.5.1.1. Overview,
11.5.1.2. Products & Services,
11.5.1.3. SWOT Analysis,
11.5.1.4. Recent Developments,
11.5.1.5. Strategies,
11.5.1.6. Financials (Based on Availability)
11.5.2. Alcon
11.5.2.1. Overview,
11.5.2.2. Products & Services,
11.5.2.3. SWOT Analysis,
11.5.2.4. Recent Developments,
11.5.2.5. Strategies,
11.5.2.6. Financials (Based on Availability)
11.5.3. Santen Pharmaceutical Co., Ltd.
11.5.3.1. Overview,
11.5.3.2. Products & Services,
11.5.3.3. SWOT Analysis,
11.5.3.4. Recent Developments,
11.5.3.5. Strategies,
11.5.3.6. Financials (Based on Availability)
11.5.4. Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)
11.5.4.1. Overview,
11.5.4.2. Products & Services,
11.5.4.3. SWOT Analysis,
11.5.4.4. Recent Developments,
11.5.4.5. Strategies,
11.5.4.6. Financials (Based on Availability)
11.5.5. Novartis AG
11.5.5.1. Overview,
11.5.5.2. Products & Services,
11.5.5.3. SWOT Analysis,
11.5.5.4. Recent Developments,
11.5.5.5. Strategies,
11.5.5.6. Financials (Based on Availability)
11.5.6. Bausch & Lomb
11.5.6.1. Overview,
11.5.6.2. Products & Services,
11.5.6.3. SWOT Analysis,
11.5.6.4. Recent Developments,
11.5.6.5. Strategies,
11.5.6.6. Financials (Based on Availability)
11.5.7. Akorn Inc.
11.5.7.1. Overview,
11.5.7.2. Products & Services,
11.5.7.3. SWOT Analysis,
11.5.7.4. Recent Developments,
11.5.7.5. Strategies,
11.5.7.6. Financials (Based on Availability)
11.5.8. Sun Pharmaceutical Industries Ltd.
11.5.8.1. Overview,
11.5.8.2. Products & Services,
11.5.8.3. SWOT Analysis,
11.5.8.4. Recent Developments,
11.5.8.5. Strategies,
11.5.8.6. Financials (Based on Availability)
11.5.9. Johnson & Johnson
11.5.9.1. Overview,
11.5.9.2. Products & Services,
11.5.9.3. SWOT Analysis,
11.5.9.4. Recent Developments,
11.5.9.5. Strategies,
11.5.9.6. Financials (Based on Availability)
11.5.10. Bayer AG
11.5.10.1. Overview,
11.5.10.2. Products & Services,
11.5.10.3. SWOT Analysis,
11.5.10.4. Recent Developments,
11.5.10.5. Strategies,
11.5.10.6. Financials (Based on Availability)
12. Strategic Recommendations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us